|
Past Weekly
Updates
|
- Dec. 6, 2013
- Nov. 14, 2013
- Oct 16, 2013
- Oct 10, 2013
- Oct. 3, 2013
- Sep. 27, 2013
- Sep. 18, 2013
- Sep. 12, 2013
- August 29, 2013
- August 19, 2013
- August 12, 2013
- August 5, 2013
- July 26, 2013
- July 15, 2013
- July 2, 2013
- June 21, 2013
- June 13, 2013
- June 7, 2013
|
|
Cut Cost of Doing Business
| |
Join the SoCalBio Group Purchasing Program to enjoy significant savings on lab supplies and equipment from
Click here to learn more
For more info, call SoCalBio at
800-418-7079 ext 3
|
Join SoCalBio
Join SoCalBio leaders to promote the biotech and device industries in Los Angeles, Orange County and neighboring communities for job creation and overall economic growth.
|  |
| Thanks to SoCalBio Media Partners
|
|
|
| Funding | |
The Culver City-Based Indi Molecular Raises $1.8 Million in Seed Funding
 Led by Dr. Albert Lauderer (photo right), Indi Molecular raised its $1.8 million from InterWest Partners and Asset Management Ventures. The funds are being used to further develop PCC (protein catalyzed capture) agent technology: a breakthrough process that produces synthetic peptide molecules capable of binding interactions that are equivalent or superior to molecular antibodies.... Learn more |
| Finance | |
Response Genetics Announces Public Offering
Stock Sale Could Net $4.8 Million
The Los Angeles-based Response Genetics, Inc. (Nasdaq:RGDX), a company focused on the development and sale of molecular diagnostic tests that help determine a patient's response to cancer therapy, announced on Dec 12 that it intends to offer and sell registered shares of its common stock in an underwritten public offering. The Company expects to use the net proceeds of the offering for working capital and general corporate purposes ... Read more
|
| Cancer Vaccine Study | |
The Calabasas-Based ImmunoCellular Therapeutics Announces Brian Cancer Vaccine Study Did Not Meet Primary Endpoint of Overall Survival
Company stock price loses over 50% of its value
 In a press release, the company said that its " dendritic cell-based vaccine, demonstrated a statistically significant increase in progression-free survival (PFS) in patients with newly diagnosed glioblastoma multiforme (GBM) in its randomized, placebo-controlled phase II trial." But the company acknowledged that the differences in the overall survival ... did not reach statistical significance in the intent-to-treat population (the primary endpoint) or the per-protocol population ... learn more
See ImmunoCellular's stock information at MarketWatch
Read commentary by Fierce Biotech
|
| Pain Drug Study | |
The Aliso Viejo-Based Avanir Tumbles on Discouraging Phase II Pain Drug Study Results
In a 209-patient trial, Avanir's AVP-923 charted reductions in neuropathic pain in line with previous studies, the company said, and the treatment led to statistically significant improvement over baseline levels for MS patients. Unfortunately, so did a fake drug, and, in a terse embrace of the obvious, Avanir stated it "believes that a higher than expected placebo response negatively impacted the study results" ... Read more at FierceBiotech
|
|
Events
| |
SoCalBio New Member Meeting
Thursday, December 19, 2013 from 10:30 AM to 2:00 PM (PST)
SoCalBio Office in Downtown Los Angeles
This is a complimentary event but registration is a MUST
Join us for networking and learning more about SoCalBio and the bioscience industry in Southern California
---------------------------------------------------------
Mark Your Calendar
UCLA's 2nd Annual Medical Device Partnering Conference on March 11, 2014
|
|
New SoCalBio Members
|
Clear Catheters Systems, Inc. (Anaheim)
 Led by CEO Paul Molly (photo right), Clear Catheter Systems, a spinout from a collaboration between MDI Partners (a medical device incubator) and the Cleveland Clinic Foundation, is a Bend, Oregon based privately held medical device company pioneering new technologies to solve the clinical problems associated with obstructed catheters... Learn more
API Vanguard (Irvine)
A supplier of pharmaceutical ingredients ... Learn more
Dr. Marion Digital (Torrance)
Dr. Marion Digital is a telehealth company that provides tools and other online applications to empower elderly care ... Learn more
BAM Architcture Studios (Los Angeles)
BAM Architecture Studio is a full service architecture practice providing design, consulting and master planning services to commercial and institutional clients ... Learn more
Other Recent Members
|
|
NIH Grants
| |
35 Greater Los Angeles Bioscience Companies Attract About $16 Million in NIH SBIR/STTR Grant
Funding in 2013
The list of grant winners below is accumulated from the NIH web site and includes competing new SBIR/STTR grants awarded in 2013 to companies located in Los Angeles, Orange, Ventura, Santa Barbara, Riverside and San Bernardino counties..
| Company | City | Grant Amount | Project Title | | AMBRYX BIOTECHNOLOGY | Riverside | $217,059 | EVALUATING NOVEL MULTI-KINASE PEPTIDE INHIBITORS AS A TREATMENT FOR RHEUMATOID AR | | ANASYS INSTRUMENTS CORPORATION | Satna Barbara | $151,627 | SINGLE CELL CHEMICAL IMAGING VIA NANOSCALE IR ABLATION - MASS SPECTROMETY | | APPLIED INTEGRIN SCIENCES | Los Angeles | $299,937 | A NOVEL BRACHYTHERAPY AGENT FOR GBM | | ARLENE FINK ASSOCIATES | Los Angeles | $149,041 | ONLINE EDUCATION TO INFORM THE ELDERLY ABOUT AGE-RELATED ALCOHOL RISKS | | ARMAGEN TECHNOLOGIES | Santa Monica | $391,592 | MANUFACTURING OF TROJAN HORSE-TNFR DECOY RECEPTOR FUSION PROTEIN | | ARMAGEN TECHNOLOGIES | Santa Monica | $416,309 | METACHROMATIC LEUKODYSTROPHY ENZYME DRUG DEVELOPMENT | | AURITEC PHARMACEUTICALS | Santa Monica | $563,622 | DEPOT INTRA-ARTICULAR FLUTICASONE FOR THE TREATMENT OF ARTHRITIS | | BIOPICO | Irvine | $249,586 | HIGH THROUGHPUT ELECTROPHYSIOLOGICAL PURIFICATION ARRAY (HEPA) FOR CELL BASED THERAPIES | | BIOSTRUXS | Westlake Village | $497,155 | DEVELOPMENT OF THE BIOBREAST | | BLUE MARBLE REHABILITATION | Los Angeles | $192,382 | HEALTH IN MOTION- DIGITALLY INTERACTIVE TAI CHI HOME EXERCISES FOR SAFER MOBILITY | | CAPRICOR | Los Angeles | $999,912 | SAFETY OF ALLOGENEIC CARDIOSPHERE-DERIVED CELLS FOR ACUTE MYOCARDIAL INFARCTION | | CLARITRAC | Los Angeles | $200,958 | MODULAR ULTRASONIC BEACON SYSTEM (MUBS) FOR ULTRASOUND-GUIDED INTERVENTIONAL SURGERY | | CYTOLUMINA TECHNOLOGIES CORPORATION, INC | Walnut | $200,465 | A MICROCHIP WITH THERMALLY RESPONSIVE POLYMERS FOR CAPTURE AND RECOVERY OF CTCS | | ENDOCOLE | Santa Barbara | $144,150 | MEDICAL DEVICE TO ENHANCE COLORECTAL CANCER SCREENING VIA MORE EFFICIENT APPLICAT | | GRIFFIN LABORATORIES | Temecula | $474,275 | DEVELOPMENT OF AN ELECTROMYOGRAPHICALLY CONTROLLED ELECTROLARYNX VOICE PROSTHESIS | | INTAN TECHNOLOGIES | Los Angeles | $184,817 | A CUSTOM MICROCHIP AMPLIFIER FOR PATCH CLAMP ELECTROPHYSIOLOGICAL RECORDING | | INTELLIGENT OPTICAL SYSTEMS | Torrance | $739,287 | NON-INVASIVE BLOOD ALCOHOL SENSOR FOR EMERGENCY ROOM APPLICATIONS | | INTELLIGENT OPTICAL SYSTEMS | Torrance | $241,853 | ELECTRO-OPTICALLY MODULATED SPR: DENSELY MULTIPLEXED HIGH-SENSITIVITY BIOSENSOR | | INTELLIGENT OPTICAL SYSTEMS | Torrance | $326,224 | PULSE OXIMETER FOR NEWBORN SCREENING | | INTELLIGENT OPTICAL SYSTEMS | Torrance | $300,046 | MULTIANALYTE NANOPROBE FOR NEUROCHEMICALS | | JPTECHNOLOGIES | Irvine | $150,000 | WIRELESS SENSOR INSERTS FOR COMBATING INCONTINENCE-ASSOCIATED DERMATITIS | | LIBREDE | Los Angeles | $591,837 | HUMAN ION CHANNEL PHARMACOLOGY IN DROPLET BILAYER MEMBRANES | | MAX BIOPHARMA | Los Angeles | $147,188 | SYNTHESIS OF BONE-SELECTIVE OSTEOGENIC OXYSTEROLS | | MODULATED IMAGING | Irvine | $735,310 | MODULATED IMAGING: A WIDE-FIELD OPTICAL IMAGING PLATFORM FOR CLINICAL RESEARCH | | MOLECULAR EXPRESS | Rancho Dominguez | $299,999 | NOVEL VLP ADJUVANT BASED ON THE VESIVAX SYSTEM | | MOLECULAR EXPRESS | Rancho Dominguez | $294,301 | DEVELOPMENT OF VESIVAX CARBOHYDRATE CONJUGATION CHEMISTRY | | NESHER TECHNOLOGIES | Los Angeles | $228,666 | MULTIPLEXED PROTEIN & MIRNA BIOMARKER-BASED NEXT-GEN TEST FOR ALZHEIMERS DISEASE | | NESHER TECHNOLOGIES | Los Angeles | $150,000 | MULTIPLEX ALEX-BASED TEST FOR PROTEASE ACTIVITY PROFILING IN ARTHRITIC JOINTS | | NEUROENABLING TECHNOLOGIES | Los Angeles | $206,411 | RESTORING ARM AND HAND MOTOR FUNCTION WITH NON-INVASIVE SPINAL STIMULATION. | | NEUROENABLING TECHNOLOGIES | Los Angeles | $346,207 | A THERANOSTIC TOOL TO ASSESS AND ENABLE SPARED SPINAL MOTOR FUNCTION AFTER SCI | | NEUROINDX INC. | Signal Hills | $580,205 | LOW-COST MICRODISSECTION SYSTEM FOR LIVE BRAIN CELL COLLECTION (CTAS-LIVE) | | NEUROSIGMA | Los Angeles | $305,058 | DEVELOPMENT OF AN IMPLANTABLE TRIGEMINAL NERVE STIMULATION SYSTEM FOR DRUG RESIST | | OCT MEDICAL IMAGING | Irvine | $928,500 | OFFICE BASED REAL-TIME HIGH SPEED 3D-OCT SYSTEM FOR DIAGNOSIS OF EARLY LARYNGEAL CANCER | | OLFACTOR LABORATORIES | Riverside | $180,636 | PREVENTION OF MOSQUITO-BORNE ILLNESS THROUGH MANIPULATION OF THE CO2 RECEPTOR | | PHYSICAL OPTICS CORPORATION | Torrance | $499,997 | MAGNETIC THROUGH-THE-EARTH MINER TRANSCEIVER FOR EMERGENCY COMMUNICATIONS | | PHYSICAL OPTICS CORPORATION | Torrance | $140,023 | LIGHT-ALARMING PERSONAL NOISE DOSIMETER SYSTEM | | SCARLESS LABORATORIES | Beverly Hills | $199,740 | A NOVEL ANTI-SCAR PEPTIDE FOR CUTANEOUS WOUND REPAIR | | SOFIE BIOSCIENCES | Culver City | $598,378 | COMMERCIALIZATION OF A BENCHTOP RADIOSYNTHESIZER FOR THE PRODUCTION OF PET PROBES | | SYMBION RESEARCH INTERNATIONAL | Newbury Park | $100,000 | TISSUE IRON MEASUREMENT BY MRI: A NEW APPROACH TO ANALYSIS; TRAINING AND CERTIFIC | | SYNEDGEN | Claremont | $149,901 | MUCOLYTIC FOR ENHANCED MUCUS AND BIOFILM CLEARANCE IN CYSTIC FIBROSIS PATIENTS | | SYNZYME TECHNOLOGY | Irvine | $957,098 | POLYNITROXYLATED PEGYLATED HEMOGLOBIN FOR TRAUMATIC BRIAN INJURY RESUSCITATION | | VASGENE THERAPEUTICS, INC | Los Angeles | $811,279 | DEVELOPMENT OF SEPHB4-HSA AS NOVEL THERAPEUTIC IN CANCER | | XONA MICROFLUIDICS | Temecula | $348,284 | A USER-FRIENDLY SCALABLE MICROFLUIDIC PLATFORM FOR ENHANCED NEURON-CELL CULTURE |
|
| Personnel Move |
Former CEO of Kite Pharmaceuticals Aya Jakobovits, PhD, Joins Orbimed
 Most recently, Dr. Jakobovits (photo rightr) was the President and Founding CEO of Kite Pharma in West Los Angeles. Previously, she served as the Executive Vice President, Head of Research and Development at Agensys that was acquired by Astellas Pharmaceuticals for up to $537 million. Prior to that, Aya was Director, Discovery Research, Principal Scientist and a scientific founder of Abgenix, which was acquired by Amgen for $2.2 billion. Orbimed is a healthcare fund with $7 billion under management. The fund had been an early investor in both Abgenix and Agensys.... Learn more |
| Jobs ... Jobs ... jobs |
SoCalBio Is Pleased to Announce Over 250 New Jobs Available at the following Greater Los Angeles Bioscience Companies
- Abbott Vascular (Temecula)
- Advanced Sterilization Products -- A Johnson & Johnson Company (Irvine)
- Agensys -- An Astellas Pharma Company (Santa Monica)
- Alcon (Irvine)
- Alfred Mann Foundation for Scientific Research (Santa Clarita)
- Alliance Medical Products (Irvine)
- Ambry Genetics (Aliso Viejo)
- Anthrex California (Walnut)
- Anthrex California Technology (Santa Barbara)
- Beckman Coulter -- A Danaher Company (Brea)
- Bioscreen Testing Services (Torrance)
- Biosense Webster -- A Johnson & Johnson Company (Irwindale & Diamond Bar)
- Boston Scientific Neuromodulation (Santa Clarita)
- Caldera Medical (Agoura Hills)
- ChromoLogic (Pasadena)
- CombiMatrix (Irvine)
- Dako (Carpinteria)
- ..... and many more
Click Here to Access the SoCalBio Links to Jobs
|
|
| About SoCalBio |
 SoCalBio membership links you to partners, contract manufacturers, regulatory and legal experts, and policy makers. The organization's programs help emerging biotech and medical device companies grow. Membership is affordable -- as low as $500 -- and offers access to networking opportunities, advocacy, discounts through our group purchasing program group purchasing program and other benefits you simply can't find elsewhere ... Join SoCalBio |
| Join SoCalBio | |
|
|
|
